PHI with Malignant pleural mesothelioma

How does this condition affect your private health insurance?

Rippenfellkarzinom, also known as pleural mesothelioma, is a rare but highly aggressive cancer originating in the pleura, the lining of the lungs. Its primary cause is prolonged exposure to asbestos fibers. Symptoms often develop decades after exposure and typically include shortness of breath, chest pain, and unexplained weight loss. Diagnosis is challenging and usually involves imaging, biopsy, and immunohistochemistry. The disease progresses rapidly, leading to significant respiratory compromise. Treatment options, often palliative, include surgery, chemotherapy, and radiation, but a cure is uncommon due to its late detection and invasive nature.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Several months to over one year from symptom onset to diagnosis and initial treatment.

Duration of Illness (Lifetime)

Generally 12-21 months after diagnosis; a terminal illness.

Cost of Treatment (Initial)

Very high (tens of thousands to hundreds of thousands of USD).

Cost of Treatment (Lifetime)

Extremely high (hundreds of thousands of USD).

Mortality Rate

Extremely high (over 90% within 5 years).

Risk of Secondary Damages

High (respiratory failure, severe pain, cachexia, mental health impacts).

Probability of Full Recovery

Very low (less than 5%).

Underlying Disease Risk

Moderate to high, particularly for asbestos-related conditions like asbestosis or pleural plaques.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.